Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.78 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.62 |
| ▸ | IGF2R | P11717 | 4/20 | 0.58 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.44 |
| ▸ | UMPS | P11172 | 2/20 | 0.43 |
| ▸ | ATIC | P31939 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4323207 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL15628068 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL977102 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL9117406 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL345396 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL799813 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL48379 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL21926734 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL22107998 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL742653 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | disclosed |
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | disclosed |
| US-20160168607-A1 | Inositol Biotransformation | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2016-06-16 | — | — | US | disclosed |
| US-20160161490-A1 | REAGENT FOR MEASURING ENDOTOXIN AND METHOD FOR MEASURING ENDOTOXIN | SAWAI PHARMACEUTICAL CO., LTD. (JP) | 2016-06-09 | — | — | US | disclosed |
| WO-2015144282-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2015-10-01 | — | — | WO | disclosed |
| US-20140086861-A1 | HYDROPHILIC TREATED PIGMENTS DISPERSIBLE IN A COSMETIC COMPOSITION | SENSIENT COSMETIC TECHNOLOGIES (FR) | 2014-03-27 | — | — | US | disclosed |
| US-7994402-B2 | Method of increasing plant organ and seed size in a plant | MONSANTO TECHNOLOGY LLC (US) | 2011-08-09 | — | — | US | disclosed |
| US-20090133162-A1 | Method of increasing plant organ and seed size in a plant | FERNANDES MARY | 2009-05-21 | — | — | US | disclosed |
| US-7335812-B2 | Method of increasing plant organ and seed size in a plant | MONSANTO TECHNOLOGY LLC (US) | 2008-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170112948-A1 | Inorganic-organic hybrid compound | SLCO4C1, SLCO2A1, SLCO1A2 | FBP1 2998/4885AMDHD2 1998/4885IGF2R 530/4885 |
| US-20140086861-A1 | HYDROPHILIC TREATED PIGMENTS DISPERSIBLE IN A COSMETIC COMPOSITION | TYR, CUTA, MITF | FBP1 4731/4885AMDHD2 922/4885IGF2R 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.